SCHEMBL528021

SCHEMBL528021

COc1cnc(C(N)=O)c(C2CCNCC2)c1Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 3/20 0.42
▸ SLC6A2 P23975 3/20 0.42
▸ SLC6A4 P31645 3/20 0.42
▸ SLC6A3 Q01959 3/20 0.42
▸ GABRA1 P14867 2/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ HTR2C P28335 2/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ CDK4 P11802 1/20 0.39
▸ CCND1 P24385 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ PRMT5 O14744 2/20 0.39
▸ FLT4 P35916 1/20 0.38
▸ PTK2 Q05397 1/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ IRAK4 Q9NWZ3 1/20 0.37
▸ KIT P10721 2/20 0.37
▸ GABRB2 P47870 1/20 0.36
▸ CAMK2D Q13557 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12467974 0.76 GABRA1 (0.43) HTR1ASLC6A2SLC6A4SLC6A3GABRA1
SCHEMBL12467968 0.70 GABRA1 (0.44) HTR1ASLC6A2SLC6A4SLC6A3GABRA1
SCHEMBL22397243 0.70 MAPT (0.42) KIT
SCHEMBL528018 0.70 SLC6A2 (0.48) HTR1ASLC6A2SLC6A4SLC6A3HTR2C
SCHEMBL8598701 0.69 GABRA1 (0.44) HTR1ASLC6A2SLC6A4SLC6A3GABRA1
SCHEMBL528020 0.67 HTR6 (0.40) HTR1ASLC6A2SLC6A4SLC6A3CDK2
SCHEMBL10626000 0.67 ALDH1A1 (0.41) HTR1A
SCHEMBL28787940 0.65 GABRA1 (0.43) HTR1ASLC6A2SLC6A4SLC6A3GABRA1
SCHEMBL2264921 0.65 PTPN1 (0.48) HTR1A
SCHEMBL28778944 0.63 MAPT (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598483-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME Rigel Pharmaceuticals, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012016217-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2012-02-02 — — WO disclosed
Send feedback